Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Microchip Technology Inc. (MCHP) vs Marsh & McLennan Companies, Inc. (MRSH) Price & Performance

Microchip Technology Inc.Trade
Marsh & McLennan Companies, Inc.Trade

Price performance (Past 24H)

Key statistics

Microchip Technology Inc. vs Marsh & McLennan Companies, Inc. — how do they compare? Microchip Technology Inc. trades at $75.55 (market cap $41.01B), while Marsh & McLennan Companies, Inc. trades at $175.76 (market cap $84.31B). The key difference: Marsh & McLennan Companies, Inc. is far larger — about 2.1× Microchip Technology Inc.'s market cap, and Microchip Technology Inc. pays the higher dividend (2.41%). Which is the better fit depends on your goals — on Pluang, investors hold Microchip Technology Inc. for 63 Days and Marsh & McLennan Companies, Inc. for 109 Days on average.

MCHPMRSH
Market Cap
$41.01B$84.31B
Volume
9,972,5163,948,947
Sector
TechnologyFinancials
52-Week High
$102.97$207.02
52-Week Low
$49.02$157.32
Typical Hold Time
63 Days109 Days
Enterprise Value
$46.13B$104.99B
Dividend Yield
2.41%2.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Microchip Technology Inc.

MCHP trades at $75.52, down 3.2% over 24 hours, with a bearish technical signal from moving averages. The company reported a net loss of -$500K in 2025, though it has beaten EPS estimates in recent quarters. Analyst consensus is strongly bullish with a $110.50 price target, supported by positive news on product expansions in Ethernet and 48V power portfolios and the completion of the Hailo acquisition.

The outlook is mixed: strong analyst support and strategic expansions in high-growth areas like AI and automotive present upside, but high valuation ratios, significant debt, and recent profitability challenges pose risks. Investor sentiment is cautiously optimistic amid sector tailwinds.

Marsh & McLennan Companies, Inc.

Marsh (MRSH) trades at $176.67, up 1.73% today, near its consensus price target of $202.71. The stock shows a bullish technical trend with support at $174 and resistance at $178. Recent earnings beats and the acquisition of Accel Holdings highlight strong operational momentum. Revenue grew to $27.0B in 2025, with a net income margin of 14.24% and a P/E ratio of 21.57, indicating solid profitability amid moderate valuation.

The outlook remains positive with consistent earnings outperformance and strategic acquisitions driving growth. Risks include elevated debt levels and potential margin pressure. Analysts are mostly neutral (65% Hold), but the stock offers upside to the price target. Investors should weigh strong cash flow generation against macroeconomic sensitivities in the insurance sector.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

MCHP
65% Buy35% Sell
Avg holding period · 63 Days
MRSH
100% Buy0% Sell
Avg holding period · 109 Days

Top news

Latest headlines on both assets

About Microchip Technology Inc.

Microchip became an independent company in 1989 when it was spun off from General Instrument. More than half of revenue comes from MCUs, which are used in a wide array of electronic devices from remote controls to garage door openers to power windows in autos. The company's strength lies in lower-end 8-bit MCUs that are suitable for a wider range of less technologically advanced devices, but the firm has expanded its presence in higher-end MCUs and analog chips as well.

Read more on MCHP →

About Marsh & McLennan Companies, Inc.

Marsh & McLennan Companies Inc is a professional services firm that provides advice and solutions in the areas of risk, strategy, and human capital. The company operates through two main segments: risk and insurance services and consulting. In risk and insurance services, the firm offers services via Marsh (an insurance broker) and Guy Carpenter (a risk and reinsurance specialist). The consulting division comprises Mercer (a provider of human resource services) and Oliver Wyman (management and economic consultancy).

Read more on MRSH →